iRhythm Technologies, Inc., a digital healthcare company, provides ambulatory electrocardiogram (ECG) monitoring products for patients at risk for arrhythmias in the United States. It offers Zio service, an ambulatory cardiac monitoring solution that combines a wire-free, patch-based, and wearable biosensor with a cloud-based data analytic platform to help physicians to monitor patients and diagnose arrhythmias. The company's Zio XT and AT monitors, a single-use, wire-free, and wearable patch-based biosensors, records patient's heartbeats and ECG data. It has a development collaboration agreement with Verily Life Sciences LLC to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.
According to iRhythm Technologies, Inc.'s latest financial reports the company's current revenue (TTM) is $492.68 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Gross Profit | Ebitda | Income Before Tax | Net Income |
---|---|---|---|---|---|
2023 | $492.68 M | $331.81 M | $-96,862,000 | $-122,656,000 | $-123,406,000 |
2022 | $410.92 M | $281.63 M | $-92,139,000 | $-115,886,000 | $-116,155,000 |
2021 | $322.83 M | $213.57 M | $-83,231,000 | $-100,994,000 | $-101,361,000 |
2020 | $265.17 M | $194.89 M | $-29,152,000 | $-43,601,000 | $-43,830,000 |
2019 | $214.55 M | $162.07 M | $-40,462,000 | $-54,503,000 | $-54,568,000 |
2018 | $147.29 M | $108.71 M | $-44,950,000 | $-48,236,000 | $-48,280,000 |
2017 | $98.51 M | $70.8 M | $-24,437,000 | $-29,420,000 | $-29,420,000 |
2016 | $64.07 M | $43.19 M | $-17,087,000 | $-20,903,000 | $-20,903,000 |
2015 | $36.14 M | $21.44 M | $-21,248,000 | $-22,799,000 | $-22,799,000 |
2014 | $21.75 M | $11.16 M | $-14,816,000 | $-15,832,000 | $-15,832,000 |
2013 | $15.37 M | $6.52 M | $-11,028,000 | $-13,589,000 | $-13,589,000 |